$1.880
+0.041 (+2.18%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PCSA Prediction & Forecast by Similar Chart Analysis
Alphio's PCSA stock price prediction model matches the current Processa Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.92 (+2.37%). The 1-week path is $1.91 (+1.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Processa Pharmaceuticals Inc Stock?
Processa Pharmaceuticals Inc (PCSA) is currently trading at $1.88, significantly down from its 52-week high of $8.88, indicating a 78.21% decline over the past year. The RSI is at 61.154, suggesting it is nearing overbought territory, which could limit short-term upside. Although there has been insider buying totaling about $40,000, the stock fell 38% after announcing a $200 million acquisition, reflecting market skepticism. The main risk is the company's negative earnings trend, with an EPS of -1.75 reported recently, indicating ongoing financial struggles.
PCSA stock price ended at $1.88 on Friday, after rising +2.18%
Processa Pharmaceuticals Inc (PCSA) last closed at $1.8801, gaining +2.18%. These facts feed the 1-day and 1-week PCSA price prediction above.
Forecast Drivers
Processa Pharmaceuticals Inc (PCSA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches PCSA, ranked by similarity.
Seasonality analysis for PCSA
Historically the probability of a positive November return for PCSA is 0.00%. January offers the highest probability of a positive month at 37.70%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PCSA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $0.16 | $0.20 | $0.23 | -89.20% |
| Dec 2026 | $0.18 | $0.21 | $0.24 | -88.75% |
In 2026, Processa Pharmaceuticals Inc (PCSA) is projected to range from $0.16 to $0.24.
Processa Pharmaceuticals Inc 2026 monthly forecast
In Nov 2026, Processa Pharmaceuticals Inc is projected to average $0.20, with a low of $0.16 and high of $0.23.
In Dec 2026, Processa Pharmaceuticals Inc is projected to average $0.21, with a low of $0.18 and high of $0.24.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.